Pharmaceutical

Lilly to acquire biopharma firm Versanis for $1.9bn

Eli Lilly and Company has signed an agreement for the acquisition of biopharmaceutical firm Versanis Bio in a deal totalling $1.925bn.

Jul 17, 2023 - 20:00
Lilly to acquire biopharma firm Versanis for $1.9bn
Eli Lilly and Company has signed an agreement for the acquisition of biopharmaceutical firm Versanis Bio in a deal totalling $1.925bn.
Read the original article

Tags:

Previous Article

Korro Bio enters merger deal with Frequency Therapeutics

Next Article

Fighting AMR with a value and subscription model 

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

How to take advantage of the connected health opportunity in your next drug launch

How to take advantage of the connected health opportuni...

May 23, 2024

STAT+: General Catalyst wants to take over a safety-net health system in Akron. The city has questions

STAT+: General Catalyst wants to take over a safety-net...

Feb 1, 2024

Janssen submits sBLA to FDA for NSCLC combination therapy

Janssen submits sBLA to FDA for NSCLC combination therapy

Aug 28, 2023